Eczema Patients Have Lost Faith In Treatment: Survey
"); jQuery("#212 h3").html("

"); });
2022-09-13 HKT 20:53
A international survey has found that only 37 percent of eczema patients in the city are working on treatment plans with doctors, while two-thirds have lost hope.
GlobalSkin, an international alliance of dermatology patient organisations, initiated the study covering 330 eczema patients in the SAR, South Korea and Australia in August, with one-third of the respondents in Hong Kong.
Dermatologist Dr Johnny Chan said on Tuesday that the proportion of patients in the city seeking medical advice is “very low”.
He said more than 90 percent of them are being treated by public practitioners, but strained medical resources due to the Covid-19 pandemic have delayed their treatment.
“The queue time of every [eczema] treatment will be two to three years at the moment," he said, adding that does not taken into account the impact Covid has had on waiting times even longer.
“While they are waiting, they think the treatments will not be helping them, and may lose the faith in treatment. They think it’s just incurable, they don’t want to have any treatment anymore,” Chan said.
“Public doctors have a limited time to see a lot of patients every day."
But for moderate to severe cases, he said, "they need some more time for explanations about the disease nature: to have a more tailor-made treatment plan for the patients, and to explain any possible side effects and the way to avoid these side effects.”
Chan added that less than 10 percent of eczema sufferers had sought treatment from the private sector. He said high costs was "very much an issue" here, with 72 percent of patients saying the heavy financial burden had deterred them from visiting doctors.
Dr Marco Ho, who chairs the Hong Kong Allergy Association, said when treatment is delayed, a patients’ immune system further deregulates and their conditions worsen, hence their expectations in consultations can be over-optimistic.
“Sometimes you don’t have the best-matched medication treatment as well as therapies. They have a whole lot of ideas and their own personal belief, so end up when we say ‘control’, they say ‘cure’; when we say ‘short-term gain’, they want a ‘long-term' remission,” he said.
“At times we even think the patient needs hospitalisation [but] they can't afford to stop their work or school.”
To clear up such misinterpretations and handle mental problems when patients are suffering from skin conditions, the allergy association and a concern group under the Hong Kong Health Care Alliance launched a free online counseling service on Tuesday that will run for three months.
Mox Bank Appoints Philip Wong As Its Chief Commercial Officer
Mox Bank Limited (Mox) announced the appointment of Philip Yin Pui Wong as its Chief Commercial Officer today. In his r... Read more
AsiaPay All-in-One Card Tokenisation Hides Card Details With Encrypted Tokens
AsiaPay, a payment digitalisation service and technology provider, announced the launch of its All-in-One Card Tokenisa... Read more
Hong Kongs First Five-Year Plan Aims To Boost International Financial Centre Role
Hong Kong’s First Five-Year Plan, announced by Chief Executive John Lee, sets out an agenda that runs from 2026 to 20... Read more
HKDAP Deposits And Withdrawals Land On HashKey Ahead Of Retail Rollout
HashKey Holdings Limited announced that its licensed trading platform, HashKey Exchange, has officially launched deposi... Read more
Anchorpoint Taps PWC Hong Kong To Drive Education On Tokenised Money
Anchorpoint Financial Limited (Anchorpoint) has announced the launch of the Tokenised Money Adoption Programme (TAP), a... Read more
Hong Kong SMEs Left Behind As Large Firms Pull Ahead On AI
DBS Hong Kong has released a survey on the city’s business outlook. SMEs are adopting AI and digital tools at nearly ... Read more